Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
42,636,598
-
Share change
-
+1,746,984
-
Total reported value
-
$2,510,222,169
-
Put/Call ratio
-
147%
-
Price per share
-
$59.72
-
Number of holders
-
164
-
Value change
-
+$114,333,128
-
Number of buys
-
96
-
Number of sells
-
58
Institutional Holders of DECIPHERA PHARMACEUTICALS IN - COM (DCPH) as of Q2 2020
As of 30 Jun 2020,
DECIPHERA PHARMACEUTICALS IN - COM (DCPH) was held by
164 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
42,636,598 shares.
The largest 10 holders included
Redmile Group, LLC, VANGUARD GROUP INC, FRANKLIN RESOURCES INC, BlackRock Inc., Avoro Capital Advisors LLC, STATE STREET CORP, ArrowMark Colorado Holdings LLC, PRICE T ROWE ASSOCIATES INC /MD/, ALLIANCEBERNSTEIN L.P., and New Leaf Venture Partners, L.L.C..
This page lists
164
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.